Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Primary causes of kidney disease and mortality in dialysis-dependent children.

Okuda Y, Soohoo M, Ishikura K, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K.

Pediatr Nephrol. 2020 Feb 4. doi: 10.1007/s00467-019-04457-7. [Epub ahead of print]

PMID:
32020338
2.

Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes.

Chan EY, Webb H, Yu E, Ghiggeri GM, Kemper MJ, Ma AL, Yamamura T, Sinha A, Bagga A, Hogan J, Dossier C, Vivarelli M, Liu ID, Kamei K, Ishikura K, Saini P, Tullus K.

Kidney Int. 2020 Feb;97(2):393-401. doi: 10.1016/j.kint.2019.09.033. Epub 2019 Oct 31.

PMID:
31874801
3.

Inherited salt-losing tubulopathy: an old condition but a new category of tubulopathy.

Nozu K, Yamamura T, Horinouchi T, Nagano C, Sakakibara N, Ishikura K, Hamada R, Morisada N, Iijima K.

Pediatr Int. 2019 Dec 12. doi: 10.1111/ped.14089. [Epub ahead of print] Review.

PMID:
31830341
4.

Long-term outcomes of pediatric kidney transplantation: A single-center experience over the past 34 years in Japan.

Aoki Y, Hamasaki Y, Satoh H, Matsui Z, Muramatsu M, Hamada R, Harada R, Ishikura K, Hataya H, Honda M, Sakai K, Shishido S.

Int J Urol. 2020 Feb;27(2):172-178. doi: 10.1111/iju.14160. Epub 2019 Dec 11.

PMID:
31826334
5.

Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study).

Sato M, Ishikura K, Ando T, Kikunaga K, Terano C, Hamada R, Ishimori S, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M.

Nephrol Dial Transplant. 2019 Sep 24. pii: gfz185. doi: 10.1093/ndt/gfz185. [Epub ahead of print]

PMID:
31550360
6.

Invasive Salmonella Enteritidis infection complicated by bacterial meningitis and vertebral osteomyelitis shortly after influenza A infection in an immunocompetent young adult.

Ikejiri K, Suzuki K, Ito A, Yasuda K, Shindo A, Ishikura K, Imai H.

J Infect Chemother. 2020 Feb;26(2):269-273. doi: 10.1016/j.jiac.2019.08.001. Epub 2019 Aug 21.

PMID:
31445818
7.
8.

Clinical characteristics of HNF1B-related disorders in a Japanese population.

Nagano C, Morisada N, Nozu K, Kamei K, Tanaka R, Kanda S, Shiona S, Araki Y, Ohara S, Matsumura C, Kasahara K, Mori Y, Seo A, Miura K, Washiyama M, Sugimoto K, Harada R, Tazoe S, Kourakata H, Enseki M, Aotani D, Yamada T, Sakakibara N, Yamamura T, Minamikawa S, Ishikura K, Ito S, Hattori M, Iijima K.

Clin Exp Nephrol. 2019 Sep;23(9):1119-1129. doi: 10.1007/s10157-019-01747-0. Epub 2019 May 27.

PMID:
31131422
9.

Treatment guidelines for persistent cloaca, cloacal exstrophy, and Mayer-Rokitansky-Küster-Häuser syndrome for the appropriate transitional care of patients.

Kubota M, Osuga Y, Kato K, Ishikura K, Kaneko K, Akazawa K, Yonekura T, Tazuke Y, Ieiri S, Fujino A, Ueno S, Hayashi Y, Yoshino K, Yanai T, Iwai J, Yamaguchi T, Amae S, Yamazaki Y, Sugita Y, Kohno M, Kanamori Y, Bitoh Y, Shinkai M, Ohno Y, Kinoshita Y.

Surg Today. 2019 Dec;49(12):985-1002. doi: 10.1007/s00595-019-01810-z. Epub 2019 Apr 22. Review.

PMID:
31011869
10.

Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys-Drash syndrome and congenital nephrotic syndrome of the Finnish type.

Nishi K, Inoguchi T, Kamei K, Hamada R, Hataya H, Ogura M, Sato M, Yoshioka T, Ogata K, Ito S, Nakanishi K, Nozu K, Hamasaki Y, Ishikura K.

Clin Exp Nephrol. 2019 Aug;23(8):1058-1065. doi: 10.1007/s10157-019-01732-7. Epub 2019 Apr 8.

PMID:
30963316
11.

Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution.

Ishiwa S, Sato M, Morisada N, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Kosuga M, Kamei K, Ito S, Nozu K, Iijima K, Ishikura K.

Pediatr Nephrol. 2019 Aug;34(8):1457-1464. doi: 10.1007/s00467-019-04230-w. Epub 2019 Apr 1.

PMID:
30937553
12.

Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.

Suzuki K, Matsumoto T, Iwashita Y, Ishikura K, Fujioka M, Wada H, Katayama N, Imai H.

Int J Hematol. 2019 Jun;109(6):737-743. doi: 10.1007/s12185-019-02604-2. Epub 2019 Jan 24.

PMID:
30680669
13.

Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report.

Saida K, Kamei K, Ogura M, Matsumura S, Kano Y, Sato M, Andoh A, Ishikura K.

Transplant Proc. 2018 Dec;50(10):3925-3927. doi: 10.1016/j.transproceed.2018.04.039. Epub 2018 Apr 18.

PMID:
30577288
14.

Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K.

Pediatr Nephrol. 2020 Jan;35(1):17-24. doi: 10.1007/s00467-018-4166-1. Epub 2018 Dec 18. Review.

PMID:
30564879
15.

Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?

Saida K, Ogura M, Kano Y, Ishimori S, Yoshikawa T, Nagata H, Sato M, Kamei K, Ishikura K.

BMC Nephrol. 2018 Dec 17;19(1):365. doi: 10.1186/s12882-018-1168-y.

16.

Effect of Ninjin'yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice.

Ohsawa M, Maruoka J, Inami C, Iwaki A, Murakami T, Ishikura KI.

Front Pharmacol. 2018 Nov 30;9:1400. doi: 10.3389/fphar.2018.01400. eCollection 2018.

17.

Favorable Kidney Function in Pediatric Liver Transplant Recipients: Results of a Single-center Cohort Study.

Sato M, Kaneko T, Ogura M, Kamei K, Ito S, Fukuda A, Sakamoto S, Kasahara M, Ishikura K.

Transplantation. 2019 Aug;103(8):1655-1662. doi: 10.1097/TP.0000000000002548.

PMID:
30489480
18.

Astrocyte-neuron lactate shuttle sensitizes nociceptive transmission in the spinal cord.

Miyamoto K, Ishikura KI, Kume K, Ohsawa M.

Glia. 2019 Jan;67(1):27-36. doi: 10.1002/glia.23474. Epub 2018 Nov 14.

PMID:
30430652
19.

No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.

Kiuchi Z, Ogura M, Sato M, Kamei K, Ishikura K, Abe J, Ito S.

Scand J Rheumatol. 2019 May;48(3):246-248. doi: 10.1080/03009742.2018.1493745. Epub 2018 Nov 8. No abstract available.

PMID:
30406708
21.

Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC).

Pediatr Nephrol. 2019 May;34(5):837-846. doi: 10.1007/s00467-018-4099-8. Epub 2018 Oct 3.

PMID:
30284023
22.

Necessity of performing voiding cystourethrography for children with unilateral multicystic dysplastic kidney.

Yamamoto K, Kamei K, Sato M, Ogura M, Suzuki M, Hasegawa Y, Ueoka K, Ito S, Ishikura K.

Pediatr Nephrol. 2019 Feb;34(2):295-299. doi: 10.1007/s00467-018-4079-z. Epub 2018 Sep 25.

PMID:
30255447
23.

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).

Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC).

BMC Nephrol. 2018 Sep 10;19(1):223. doi: 10.1186/s12882-018-1033-z.

24.

Correction to: Validation of estimated glomerular filtration rate equations for Japanese children.

Gotoh Y, Uemura O, Ishikura K, Sakai T, Hamasaki Y, Araki Y, Hamada R, Honda M; Pediatric CKD Study Group in Japan in conjunction with the Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology.

Clin Exp Nephrol. 2018 Dec;22(6):1477. doi: 10.1007/s10157-018-1623-x.

PMID:
30143903
25.

[Factors Affecting Development of Cholinergic Symptoms after Irinotecan Administration].

Mizukami Y, Okuyama H, Ishikura K, Tamura K.

Gan To Kagaku Ryoho. 2018 Jul;45(7):1087-1091. Japanese.

PMID:
30042278
26.

Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese Population.

Jia X, Horinouchi T, Hitomi Y, Shono A, Khor SS, Omae Y, Kojima K, Kawai Y, Nagasaki M, Kaku Y, Okamoto T, Ohwada Y, Ohta K, Okuda Y, Fujimaru R, Hatae K, Kumagai N, Sawanobori E, Nakazato H, Ohtsuka Y, Nakanishi K, Shima Y, Tanaka R, Ashida A, Kamei K, Ishikura K, Nozu K, Tokunaga K, Iijima K; Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan.

J Am Soc Nephrol. 2018 Aug;29(8):2189-2199. doi: 10.1681/ASN.2017080859. Epub 2018 Jul 16.

27.

Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.

Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group.

Pediatr Nephrol. 2018 Nov;33(11):2103-2112. doi: 10.1007/s00467-018-4011-6. Epub 2018 Jul 9.

PMID:
29987456
28.

Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndrome.

Unzaki A, Morisada N, Nozu K, Ye MJ, Ito S, Matsunaga T, Ishikura K, Ina S, Nagatani K, Okamoto T, Inaba Y, Ito N, Igarashi T, Kanda S, Ito K, Omune K, Iwaki T, Ueno K, Yahata M, Ohtsuka Y, Nishi E, Takahashi N, Ishikawa T, Goto S, Okamoto N, Iijima K.

J Hum Genet. 2018 May;63(5):647-656. doi: 10.1038/s10038-018-0429-8. Epub 2018 Mar 2.

PMID:
29500469
29.

Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.

Kamei K, Miyairi I, Ishikura K, Ogura M, Shoji K, Funaki T, Ito R, Arai K, Abe J, Kawai T, Onodera M, Ito S.

J Pediatr. 2018 May;196:217-222.e1. doi: 10.1016/j.jpeds.2017.12.061. Epub 2018 Feb 28.

PMID:
29499990
30.

Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome.

Kamei K, Ogura M, Sato M, Ito S, Ishikura K.

Pediatr Nephrol. 2018 Jun;33(6):1013-1018. doi: 10.1007/s00467-018-3900-z. Epub 2018 Feb 9.

PMID:
29426974
31.

Ensuring safe drug administration to pediatric patients with renal dysfunction: a multicenter study.

Harada R, Ishikura K, Shinozuka S, Mikami N, Hamada R, Hataya H, Morikawa Y, Omori T, Takahashi H, Hamasaki Y, Kaneko T, Iijima K, Honda M.

Clin Exp Nephrol. 2018 Aug;22(4):938-946. doi: 10.1007/s10157-018-1537-7. Epub 2018 Feb 6.

PMID:
29411162
32.

Validation of estimated glomerular filtration rate equations for Japanese children.

Gotoh Y, Uemura O, Ishikura K, Sakai T, Hamasaki Y, Araki Y, Hamada R, Hamda R, Honda M; Pediatric CKD Study Group in Japan in conjunction with the Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology.

Clin Exp Nephrol. 2018 Aug;22(4):931-937. doi: 10.1007/s10157-018-1529-7. Epub 2018 Jan 25. Erratum in: Clin Exp Nephrol. 2018 Dec;22(6):1477. Hamda R [corrected to Hamada R].

PMID:
29372471
33.

Nebulized hypertonic saline in infants hospitalized with moderately severe bronchiolitis due to RSV infection: A multicenter randomized controlled trial.

Morikawa Y, Miura M, Furuhata MY, Morino S, Omori T, Otsuka M, Chiga M, Obonai T, Hataya H, Kaneko T, Ishikura K, Honda M, Hasegawa Y; Tokyo Pediatric Clinical Research Network.

Pediatr Pulmonol. 2018 Mar;53(3):358-365. doi: 10.1002/ppul.23945. Epub 2018 Jan 12.

PMID:
29327810
34.

Renal replacement therapy for children throughout the world: the need for a global registry.

Ploos van Amstel S, Noordzij M, Warady BA, Cano F, Craig JC, Groothoff JW, Ishikura K, Neu A, Safouh H, Xu H, Jager KJ, Schaefer F.

Pediatr Nephrol. 2018 May;33(5):863-871. doi: 10.1007/s00467-017-3863-5. Epub 2017 Dec 22.

35.

Saliency Detection Based on Multiscale Extrema of Local Perceptual Color Differences.

Ishikura K, Kurita N, Chandler DM, Ohashi G.

IEEE Trans Image Process. 2018 Feb;27(2):703-717. doi: 10.1109/TIP.2017.2767288.

PMID:
29185988
36.

Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

Hamasaki Y, Muramatsu M, Hamada R, Ishikura K, Hataya H, Satou H, Honda M, Nakanishi K, Shishido S.

Clin Exp Nephrol. 2018 Jun;22(3):719-726. doi: 10.1007/s10157-017-1508-4. Epub 2017 Nov 28.

PMID:
29185126
37.

Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.

Nagata H, Sato M, Ogura M, Yoshikawa T, Yamamoto K, Matsumura S, Kano Y, Saida K, Sako M, Kamei K, Yoshioka T, Ogata K, Ito S, Ishikura K.

Nephrology (Carlton). 2018 Jun;23(6):592-596. doi: 10.1111/nep.13175.

PMID:
28976051
38.

Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study.

Ra SG, Miyazaki T, Kojima R, Komine S, Ishikura K, Kawanaka K, Honda A, Matsuzaki Y, Ohmori H.

J Sports Med Phys Fitness. 2018 Nov;58(11):1582-1591. doi: 10.23736/S0022-4707.17.07638-1. Epub 2017 Sep 22.

PMID:
28944645
39.

Creatinine-based estimated glomerular filtration rate for children younger than 2 years.

Uemura O, Ishikura K, Gotoh Y, Honda M.

Clin Exp Nephrol. 2018 Apr;22(2):483-484. doi: 10.1007/s10157-017-1460-3. Epub 2017 Sep 11. No abstract available.

PMID:
28894940
40.

Increased N-Acetyltaurine in the Skeletal Muscle After Endurance Exercise in Rat.

Miyazaki T, Nakamura Y, Ebina K, Mizushima T, Ra SG, Ishikura K, Matsuzaki Y, Ohmori H, Honda A.

Adv Exp Med Biol. 2017;975 Pt 1:403-411. doi: 10.1007/978-94-024-1079-2_33.

PMID:
28849471
41.

Current status of pediatric transplantation in Japan.

Nishimura N, Kasahara M, Ishikura K, Nakagawa S.

J Intensive Care. 2017 Jul 20;5:48. doi: 10.1186/s40560-017-0241-0. eCollection 2017. Review.

42.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.

Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K; Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group.

Pediatr Nephrol. 2017 Nov;32(11):2071-2078. doi: 10.1007/s00467-017-3718-0. Epub 2017 Jun 29.

PMID:
28664242
43.

Diversity of renal phenotypes in patients with WDR19 mutations: Two case reports.

Yoshikawa T, Kamei K, Nagata H, Saida K, Sato M, Ogura M, Ito S, Miyazaki O, Urushihara M, Kondo S, Sugawara N, Ishizuka K, Hamasaki Y, Shishido S, Morisada N, Iijima K, Nagata M, Yoshioka T, Ogata K, Ishikura K.

Nephrology (Carlton). 2017 Jul;22(7):566-571. doi: 10.1111/nep.12996.

PMID:
28621010
44.

Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.

Sato M, Kamei K, Ogura M, Ishikura K, Ito S.

Clin Exp Nephrol. 2018 Feb;22(1):110-116. doi: 10.1007/s10157-017-1415-8. Epub 2017 Apr 22.

PMID:
28434126
45.
46.

Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients.

Terano C, Ishikura K, Hamada R, Yoshida Y, Kubota W, Okuda Y, Shinozuka S, Harada R, Iyoda S, Fujimura Y, Hamasaki Y, Hataya H, Honda M.

Nephrology (Carlton). 2018 Jun;23(6):539-545. doi: 10.1111/nep.13054.

PMID:
28387984
47.

Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.

Hamasaki Y, Komaki F, Ishikura K, Hamada R, Sakai T, Hataya H, Ogata K, Ando T, Honda M.

Pediatr Nephrol. 2017 Aug;32(8):1383-1390. doi: 10.1007/s00467-017-3641-4. Epub 2017 Apr 4.

PMID:
28378029
48.

Successful resumption of peritoneal dialysis following living donor liver transplantation in children with end-stage renal disease.

Kanazawa H, Fukuda A, Sato M, Ishimori S, Sasaki K, Uchida H, Shigeta T, Mali VP, Sakamoto S, Ishikura K, Kasahara M.

Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12897. Epub 2017 Feb 18.

PMID:
28213931
49.

Effects of low-dose tolvaptan on electrolyte abnormality and hemodynamic parameters in a liver cirrhosis-associated portopulmonary hypertension patient: A case report.

Ogihara Y, Yamada N, Dohi K, Matsuda A, Ota S, Ishikura K, Nakamura M, Ito M.

Exp Ther Med. 2017 Jan;13(1):269-272. doi: 10.3892/etm.2016.3945. Epub 2016 Dec 1.

50.

The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus.

Bando Y, Ogawa A, Ishikura K, Kanehara H, Hisada A, Notumata K, Okafuji K, Toya D.

Diabetol Int. 2017 Jan 3;8(2):218-227. doi: 10.1007/s13340-016-0302-y. eCollection 2017 Jun.

Supplemental Content

Loading ...
Support Center